Ligand validation:6SP8

B3P: 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)-PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL

B3P is a Ligand Of Interest in 6SP8 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6SP8_B3P_B_313	32%	54%	0.14	0.814	0.69	1.07	-	2	0	0	100%	0.82
6SP8_B3P_A_316	24%	50%	0.151	0.776	0.63	1.31	-	1	0	0	100%	0.86
6SP5_B3P_B_301	63%	53%	0.103	0.898	0.7	1.1	-	2	0	0	100%	1
6Y7D_B3P_B_902	99%	53%	0.048	0.975	0.77	1.06	-	1	1	0	100%	1
6TJK_B3P_BBB_1927	95%	59%	0.066	0.97	0.53	1.03	-	1	0	0	100%	1
4AD0_B3P_D_500	91%	39%	0.085	0.97	0.59	1.86	-	5	2	0	100%	1
7P41_B3P_D_703	89%	53%	0.073	0.95	0.83	1	-	1	0	0	100%	1
6RL0_B3P_B_701	88%	40%	0.077	0.954	0.89	1.52	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.